Randomised controlled trial of lactulose versus rifaximin for prophylaxis of hepatic encephalopathy in patients with acute variceal bleed
- PMID: 25320105
- DOI: 10.1136/gutjnl-2014-308521
Randomised controlled trial of lactulose versus rifaximin for prophylaxis of hepatic encephalopathy in patients with acute variceal bleed
Keywords: BLEEDING; CIRRHOSIS; ENCEPHALOPATHY; OESOPHAGEAL VARICES; PORTAL HYPERTENSION.
Comment on
-
Diagnosis of minimal hepatic encephalopathy: still a challenge.Gut. 2013 Oct;62(10):1394. doi: 10.1136/gutjnl-2012-304270. Epub 2013 Jan 11. Gut. 2013. PMID: 23315503 No abstract available.
Similar articles
-
Primary Prophylaxis to Prevent the Development of Hepatic Encephalopathy in Cirrhotic Patients with Acute Variceal Bleeding.Can J Gastroenterol Hepatol. 2018 Jul 10;2018:3015891. doi: 10.1155/2018/3015891. eCollection 2018. Can J Gastroenterol Hepatol. 2018. PMID: 30079329 Free PMC article. Clinical Trial.
-
Prophylaxis of hepatic encephalopathy in acute variceal bleed: a randomized controlled trial of lactulose versus no lactulose.J Gastroenterol Hepatol. 2011 Jun;26(6):996-1003. doi: 10.1111/j.1440-1746.2010.06596.x. J Gastroenterol Hepatol. 2011. PMID: 21129028 Clinical Trial.
-
RiMINI - the influence of rifaximin on minimal hepatic encephalopathy (MHE) and on the intestinal microbiome in patients with liver cirrhosis: study protocol for a randomized controlled trial.Trials. 2016 Feb 29;17(1):111. doi: 10.1186/s13063-016-1205-8. Trials. 2016. PMID: 26926775 Free PMC article. Clinical Trial.
-
The portal hypertension syndrome: etiology, classification, relevance, and animal models.Hepatol Int. 2018 Feb;12(Suppl 1):1-10. doi: 10.1007/s12072-017-9827-9. Epub 2017 Oct 24. Hepatol Int. 2018. PMID: 29064029 Review.
-
[Surgical approach to posthepatitic cirrhotic patient today].G Chir. 1996 Jun-Jul;17(6-7):370-8. G Chir. 1996. PMID: 9272983 Review. Italian.
Cited by
-
Prophylaxis of hepatic encephalopathy: current and future drug targets.Hepatol Int. 2024 Aug;18(4):1096-1109. doi: 10.1007/s12072-024-10647-9. Epub 2024 Mar 16. Hepatol Int. 2024. PMID: 38492132 Review.
-
Effect of rifaximin on gut microbiota composition in advanced liver disease and its complications.World J Gastroenterol. 2015 Nov 21;21(43):12322-33. doi: 10.3748/wjg.v21.i43.12322. World J Gastroenterol. 2015. PMID: 26604640 Free PMC article. Review.
-
Efficacy and safety of rifaximin for the prophylaxis of hepatic encephalopathy: A meta-analysis.Medicine (Baltimore). 2025 Jan 31;104(5):e39905. doi: 10.1097/MD.0000000000039905. Medicine (Baltimore). 2025. PMID: 39889173 Free PMC article.
-
Clinical management of type C hepatic encephalopathy.United European Gastroenterol J. 2020 Jun;8(5):536-543. doi: 10.1177/2050640620909675. Epub 2020 Feb 26. United European Gastroenterol J. 2020. PMID: 32213035 Free PMC article. Review.
-
Retrograde Transvenous Obliteration (RTO): A New Treatment Option for Hepatic Encephalopathy.Dig Dis Sci. 2020 Sep;65(9):2483-2491. doi: 10.1007/s10620-020-06050-7. Epub 2020 Jan 31. Dig Dis Sci. 2020. PMID: 32002756 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical